CHRISTIAN STANIEC: Open Payments
NPI 1003871849 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,914 in 81 payments from 20 companies in 2025. Trend: 2023 $1,700 · 2024 $1,812 · 2025 $1,914
Food & beverage: $1,706Education: $209
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $403 |
| GENZYME CORPORATION | 8 | $303 |
| Janssen Biotech, Inc. | 3 | $213 |
| Lilly USA, LLC | 7 | $143 |
| UCB, Inc. | 4 | $112 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76 |
| LEO Pharma Inc. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| Botanix SB Inc | 3 | $56 |
Products named: DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, Bimzelx, ILUMYA, SPEVIGO, TALTZ.
Industry payments across FL — which companies pay providers there.
